微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 58.46% | -0.14% | -0.05% | 54/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 58.49% | 4.27% | 0.49% | 58/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 58.2% | 2.34% | 0.29% | 60/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 58.03% | 0.67% | -0.86% | 61/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 58.54% | 4.68% | 4.36% | 57/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 56.09% | -2.08% | -1.37% | 65/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 56.87% | -5.87% | -1.35% | 63/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 57.65% | -5.12% | 3.08% | 62/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 55.92% | -6.93% | -2.38% | 62/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 57.28% | -0.33% | -5.19% | 60/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 60.42% | 5.78% | -0.56% | 53/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 60.76% | 4.55% | 1.12% | 53/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 60.08% | 1.97% | 4.54% | 58/131 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 57.47% | -1.46% | 0.62% | 71/131 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 57.12% | -3.12% | -1.71% | 64/131 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 58.12% | -0.6% | -1.37% | 67/131 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 58.92% | 2% | 1.03% | 58/131 | 60.75% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 58.32% | -2.87% | -1.07% | 73/131 | 59.59% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 58.96% | 2% | 0.84% | 53/131 | 61.59% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 58.46% | 2% | -2.63% | 63/131 | 59.94% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 60.04% | 2.39% | 2.39% | 59/131 | 56.37% | 正海生物 | 94.38% | 行业排名> |
| 2018-12-31 | 58.64% | -3.6% | -3.6% | 55/131 | 55.53% | 正海生物 | 93.12% | 行业排名> |
| 2017-12-31 | 60.83% | 2% | 2% | 48/131 | 55.34% | 正海生物 | 93.78% | 行业排名> |